Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

54
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 04/28 05:29:07 pm
38.7930 EUR   -4.16%
04/24 GRIFOLS : Drive nets 11,000 pounds of PB&J for Clayton food pantry
03/30 GRIFOLS : In Clayton, a push for PB&J
03/29 GRIFOLS : to make a major equity investment in Alkahest
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
04/22/2015 04/23/2015 04/24/2015 04/27/2015 04/28/2015 Date
40.735(c) 40.19(c) 40.43(c) 40.475(c) 38.92 Last
423 193 780 695 435 982 646 234 1 229 961 Volume
-0.10% -1.34% +0.60% +0.11% -3.84% Change
More quotes
Financials (€)
Sales 2015 3 727 M
EBIT 2015 931 M
Net income 2015 535 M
Debt 2015 3 153 M
Yield 2015 1,56%
Sales 2016 4 007 M
EBIT 2016 1 046 M
Net income 2016 618 M
Debt 2016 2 859 M
Yield 2016 1,81%
PER 2015 25,49
PER 2016 22,30
EV / Sales 2015 4,25x
EV / Sales 2016 3,88x
Capitalization 12 673 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/28 | 06:00amShareholder meeting
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
04/24 GRIFOLS : Drive nets 11,000 pounds of PB&J for Clayton food pantry
03/30 GRIFOLS : In Clayton, a push for PB&J
03/29 GRIFOLS : to make a major equity investment in Alkahest
03/09 GRIFOLS : to make a major equity investment in Alkahest
03/04 GRIFOLS : to make a major equity investment in Alkahest Download (380.5 Kb)
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals - Update
03/02DJNovartis, GlaxoSmithKline Complete Deals
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals
More news
Sector news : Biopharmaceuticals
11:56aDJBoston Scientific Reports Loss, Product Settlement
11:21a TEVA PHARMACEUTICAL : Mylan spurns $40B deal
10:58a SHIRE : Results of the 2015 Annual General Meeting (47KB PDF)
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/31 Is The Elixir Of Youth Closer Than We Think? A New Way Of Viewing Blood Produ..
03/02 TIGENIX : Locked And Loaded For Phase 3 Readout
02/23 Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update


Comments 
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF